E. Mendezalvarez et al., INHIBITION OF BRAIN MONOAMINE-OXIDASE BY ADDUCTS OF 1,2,3,4-TETRAHYDROISOQUINOLINE WITH COMPONENTS OF CIGARETTE-SMOKE, Life sciences, 60(19), 1997, pp. 1719-1727
Citations number
30
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
A series of adducts of 1,2,3,4-tetrahydroisoquinoline (TIQ) and some c
omponents of tobacco smoke were investigated for their ability to inhi
bit rat brain monoamine oxidase. 1-Cyano-TIQ (1CTIQ), N-(1'-cyanoethyl
)-TIQ (CETIQ), N-(1'-cyanopropyl)-TIQ (CPTIQ), and N-(1'-cyanobutyl)-T
IQ (CBTIQ) were found to act as competitive inhibitors for both MAO-A
and MAO-B. K-i values ranged from 16.4 to 37.6 mu M. N-(Cyanomethyl)-T
IQ (CMTIQ) was not found to be an inhibitor (K-i > 100 mu M). These fi
ndings may help to explain the in vivo inhibitory effects of tobacco s
moke on MAO activity and the suggested protective effect of tobacco sm
oking against Parkinson's disease. They also appear to reinforce the u
sefulness of reversible MAO inhibitors in smoking cessation and abstin
ence. However, different results must be expected between Burley and B
right tobacco.